Education
About Us
Working with TipRanks
Follow Us
Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
Total Valuation
Ascentage Pharma Group International Unsponsored ADR has a market cap or net worth of $2.28B. The enterprise value is $15.10B.
Market Cap$2.28B
Enterprise Value$15.10B
Share Statistics
Ascentage Pharma Group International Unsponsored ADR has 93,330,420 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding93,330,420
Owned by Insiders―
Owned by Institutions0.07%
Financial Efficiency
Ascentage Pharma Group International Unsponsored ADR’s return on equity (ROE) is -1.53 and return on invested capital (ROIC) is -16.58%.
Return on Equity (ROE)-1.53
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-16.58%
Return on Capital Employed (ROCE)-0.25
Revenue Per Employee1.73M
Profits Per Employee-697.10K
Employee Count567
Asset Turnover0.37
Inventory Turnover4.41
Valuation Ratios
The current PE Ratio of Ascentage Pharma Group International Unsponsored ADR is ―. Ascentage Pharma Group International Unsponsored ADR’s PEG ratio is 1.05.
PE Ratio―
PS Ratio39.07
PB Ratio145.04
Price to Fair Value145.04
Price to FCF-282.48
Price to Operating Cash Flow227.28
PEG Ratio1.05
Income Statement
In the last 12 months, Ascentage Pharma Group International Unsponsored ADR had revenue of 980.65M and earned -405.43M in profits. Earnings per share was -1.34.
Revenue980.65M
Gross Profit951.57M
Operating Income-369.73M
Pretax Income-395.25M
Net Income-405.43M
EBITDA-237.63M
Earnings Per Share (EPS)-1.34
Cash Flow
In the last 12 months, operating cash flow was 243.03M and capital expenditures -7.76M, giving a free cash flow of 235.27M billion.
Operating Cash Flow243.03M
Free Cash Flow235.27M
Free Cash Flow per Share2.52
Dividends & Yields
Ascentage Pharma Group International Unsponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.61
52-Week Price Change23.57%
50-Day Moving Average37.24
200-Day Moving Average―
Relative Strength Index (RSI)34.89
Average Volume (3m)8.43K
Important Dates
Ascentage Pharma Group International Unsponsored ADR upcoming earnings date is Apr 1, 2026, TBA (Confirmed).
Last Earnings DateAug 20, 2025
Next Earnings DateApr 1, 2026
Ex-Dividend Date―
Financial Position
Ascentage Pharma Group International Unsponsored ADR as a current ratio of 1.26, with Debt / Equity ratio of 257.68%
Current Ratio1.26
Quick Ratio1.26
Debt to Market Cap0.04
Net Debt to EBITDA-1.82
Interest Coverage Ratio-5.74
Taxes
In the past 12 months, Ascentage Pharma Group International Unsponsored ADR has paid 10.43M in taxes.
Income Tax10.43M
Effective Tax Rate-0.03
Enterprise Valuation
Ascentage Pharma Group International Unsponsored ADR EV to EBITDA ratio is -163.07, with an EV/FCF ratio of -285.67.
EV to Sales39.51
EV to EBITDA-163.07
EV to Free Cash Flow-285.67
EV to Operating Cash Flow-347.97
Balance Sheet
Ascentage Pharma Group International Unsponsored ADR has $1.66B in cash and marketable securities with $1.72B in debt, giving a net cash position of -$54.71M billion.
Cash & Marketable Securities$1.66B
Total Debt$1.72B
Net Cash-$54.71M
Net Cash Per Share-$0.59
Tangible Book Value Per Share$0.57
Margins
Gross margin is 90.87%, with operating margin of -37.70%, and net profit margin of -41.34%.
Gross Margin90.87%
Operating Margin-37.70%
Pretax Margin-40.31%
Net Profit Margin-41.34%
EBITDA Margin-24.23%
EBIT Margin-33.73%
Analyst Forecast
The average price target for Ascentage Pharma Group International Unsponsored ADR is $48.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$48.67
Price Target Upside110.06% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast-56.78%
EPS Growth Forecast-191.46%